| 词条 | CP 55,244 |
| 释义 |
| verifiedrevid = 451979965 | IUPAC_name = (2S,4S,4aS,6R,8aR)-6-(hydroxymethyl)-4-[2-hydroxy-4-(2-methyloctan-2-yl)phenyl]-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-ol | image = CP55244.png | tradename = | legal_status = | routes_of_administration = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 79678-32-3 | PubChem = 133254 | ChemSpiderID = 117567 | C=26 | H=42 | O=3 | molecular_weight = 402.608 g/mol | smiles = CCCCCCC(C)(C)c1ccc(c(c1)O)[C@H]2C[C@H](C[C@@H]3[C@@H]2C[C@@H](CC3)CO)O | StdInChI = 1S/C26H42O3/c1-4-5-6-7-12-26(2,3)20-10-11-22(25(29)15-20)24-16-21(28)14-19-9-8-18(17-27)13-23(19)24/h10-11,15,18-19,21,23-24,27-29H,4-9,12-14,16-17H2,1-3H3/t18-,19-,21+,23+,24-/m1/s1 | StdInChIKey = ZAELPWSCABXXAB-QXASVXAKSA-N }}CP 55,244 is a compound which is a cannabinoid receptor agonist. It has analgesic effects and is used in scientific research. It is an extremely potent CB1 full agonist with a Ki of 0.21nM, making it more potent than the commonly used full agonist HU-210.[1] See also
References1. ^Griffin G, Wray EJ, Martin BR, Abood ME. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. British Journal of Pharmacology. 1999 Oct;128(3):684-8. {{DOI|10.1038/sj.bjp.0702806}} {{PMID|10516649}} {{cannabinoids}}{{Hallucinogens}}{{cannabinoid-stub}} 6 : Alcohols|Cannabinoids|Decalins|Pfizer|Pfizer products|Phenols |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。